488143879	488143879	CD	B-NP	O
|	|	NN	I-NP	O
A	A	NNP	I-NP	O
&	&	CC	I-NP	O
H	H	NNP	I-NP	O
|	|	VBD	B-VP	O
85427112	85427112	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1777832	1777832	CD	B-NP	O
|	|	CC	I-NP	O
4/13/2003	4/13/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/13/2003	4/13/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
BRADLEY	BRADLEY	NNP	B-NP	O
ZENI	ZENI	NNP	I-NP	O
MD	MD	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
hematuria	hematuria	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
61-year-old	61-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
elevated	elevated	JJ	B-NP	O
ammonia	ammonia	NN	I-NP	O
levels	level	NNS	I-NP	O
chronically	chronically	RB	B-ADVP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
LVH	LVH	NN	B-NP	O
,	,	,	O	O
recently	recently	RB	B-ADVP	O
discharged	discharge	VBN	B-VP	O
from	from	IN	B-PP	O
Longlate	Longlate	NNP	B-NP	O
General	General	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
7/10	7/10	CD	B-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Ieu	Ieu	NNP	B-NP	O
University	University	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
prior	prior	JJ	I-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
encepholopathy	encepholopathy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
no	no	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
available	available	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
in	in	IN	B-PP	O
rehab	rehab	NN	B-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
2-3	2-3	CD	I-NP	O
days	day	NNS	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
with	with	IN	B-PP	O
very	very	RB	B-NP	O
minimal	minimal	JJ	I-NP	O
movement	movement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
stable	stable	JJ	B-NP	O
two	two	CD	I-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	I-NP	O
chills	chill	NNS	I-NP	O
,	,	,	I-NP	O
nausea	nausea	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
without	without	IN	B-PP	O
palpitation	palpitation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
that	that	IN	B-SBAR	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
over	over	IN	B-PP	O
past	past	JJ	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
noted	note	VBN	I-VP	O
increased	increase	VBN	B-NP	O
hematuria	hematuria	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
hematuria	hematuria	NN	I-NP	O
for	for	IN	B-PP	O
over	over	IN	B-NP	O
1-2	1-2	CD	I-NP	O
years	year	NNS	I-NP	O
per	per	IN	B-PP	O
patient	patient	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
in	in	IN	B-PP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increased	increase	VBN	B-NP	O
hematuria	hematuria	NN	I-NP	O
since	since	IN	B-PP	O
that	that	DT	B-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
``	``	``	O	O
crackles	crackle	NNS	B-NP	O
''	''	''	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
rehab	rehab	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ridwill	Ridwill	NNP	I-NP	O
Child	Child	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	VBN	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
74	74	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
127/75	127/75	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
satting	satte	VBG	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
80	80	CD	B-NP	O
IV	IV	CD	I-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	I-NP	O
Percocet	Percocet	NNP	I-NP	O
and	and	CC	I-NP	O
Lactulose	Lactulose	NNP	I-NP	O
for	for	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
ammonia	ammonia	NN	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
BNP	BNP	NN	I-NP	O
of	of	IN	B-PP	O
655	655	CD	B-NP	O
,	,	,	O	O
elevated	elevated	JJ	B-NP	O
ammonia	ammonia	NN	I-NP	O
of	of	IN	B-PP	O
83	83	CD	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Morbid	Morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
hyper	hyper	NN	I-NP	O
ammonium	ammonium	NN	I-NP	O
levels	level	NNS	I-NP	O
NH3	NH3	NN	I-NP	B-protein
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
70	70	CD	B-NP	O
to	to	TO	I-NP	O
90	90	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
prior	prior	JJ	I-NP	O
workup	workup	NN	I-NP	O
largely	largely	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
however	however	RB	B-ADJP	O
never	never	RB	I-ADJP	O
able	able	JJ	I-ADJP	O
to	to	TO	B-VP	O
image	image	VB	I-VP	O
the	the	DT	B-NP	O
abdomen	abdoman	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
LFTs	LFT	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
and	and	CC	O	O
past	past	JJ	B-NP	B-protein
troponin	troponin	NN	I-NP	I-protein
leak	leak	NN	I-NP	I-protein
early	early	RB	B-NP	I-protein
10/10	10/10	CD	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
leg	leg	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
VT	VT	NN	B-NP	O
on	on	IN	B-PP	O
sotalol	sotalol	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Migraines	Migraine	NNS	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Hypercholesterolemia	Hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
3.7	3.7	CD	I-NP	O
-	-	HYPH	I-NP	O
3.9	3.9	CD	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

BPH	BPH	NN	B-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
Targis	Targis	NNP	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Anemia	Anemia	NNP	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Anxiety	Anxiety	NN	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
myeloma	myeloma	NN	I-NP	O
,	,	,	O	O
monoclonal	monoclonal	JJ	B-NP	O
gammopathy	gammopathy	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
Cytoxan	Cytoxan	NNP	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Sotalol	Sotalol	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Klonopin	Klonopin	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Calcitriol	Calcitriol	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	O
bicarb	bicarb	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Atorvastatin	Atorvastatin	IN	B-PP	O
40	40	CD	B-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Phoslo	Phoslo	NN	B-NP	B-protein
667	667	CD	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
100	100	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Lactulose	Lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Epogen	Epogen	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

CPAP	CPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Doxepin	Doxepin	NNP	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
8	8	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	RB	B-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Proscar	Proscar	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
causing	cause	VBG	B-VP	O
rash	rash	NN	B-NP	O
and	and	CC	I-NP	O
dizziness	dizziness	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
wife	wife	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
or	or	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
82	82	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
132/72	132/72	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
420	420	CD	B-NP	O
lbs	lb	NNS	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
Morbidly	Morbidly	RB	B-ADJP	O
obese	obese	JJ	I-ADJP	O
,	,	,	O	O
speaking	speak	VBG	B-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Oropharynx	Oropharynx	NN	B-NP	O
clear	clear	JJ	I-NP	O
,	,	,	I-NP	O
anicteric	anicteric	JJ	I-NP	O
sclerae	sclerae	NNS	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
6	6	CD	I-NP	O
cm	cm	NN	I-NP	O
though	though	IN	B-SBAR	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
habitus	habitus	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
MRG	MRG	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
or	or	CC	I-NP	O
S4	S4	NN	I-NP	B-protein
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
Increased	Increase	VBN	B-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Obese	Obese	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
liver	liver	NN	I-NP	O
edge	edge	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fluid	fluid	NN	I-NP	O
wave	wave	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Lower	Low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
approximately	approximately	RB	B-NP	O
2-3	2-3	CD	I-NP	O
+	+	SYM	B-NP	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
excoriations	excoriation	NNS	I-NP	O
on	on	IN	B-PP	O
abdomen	abdoman	NNS	B-NP	O
-LRB-	-LRB-	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
they	they	PRP	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
improving	improve	VBG	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
year	year	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
ulcer/lesions	ulcer/lesion	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
lower	low	JJR	B-NP	O
legs	leg	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
.	.	.	O	O

Motor	Motor	NN	B-NP	O
strength	strength	NN	I-NP	O
someone	someone	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
proximal	proximal	JJ	B-NP	O
leg	leg	NN	I-NP	O
and	and	CC	I-NP	O
arms	arm	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
139	139	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.1	4.1	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
103	103	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
26	26	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
64	64	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
4.0	4.0	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
3.7	3.7	CD	B-NP	O
-	-	HYPH	I-NP	O
3.9	3.9	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
3.4	3.4	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
7.1	7.1	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
33.5	33.5	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
137	137	CD	B-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
baseline	baseline	NN	I-NP	I-protein
hematocrit	hematocrit	NN	I-NP	I-protein
usually	usually	RB	B-ADVP	I-protein
32-35	32-35	CD	B-NP	I-protein
-RRB-	-RRB-	HYPH	B-ADJP	I-protein
,	,	,	O	O
LFTs	LFT	NNS	B-NP	B-protein
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ALT	ALT	NN	I-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	O
,	,	,	O	O
alk	alk	NN	B-NP	O
phos	pho	NNS	I-NP	O
,	,	,	O	O
T	T	NN	B-NP	B-protein
bili	bili	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

First	First	JJ	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
ED	ED	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
655	655	CD	B-NP	O
.	.	.	O	O

Ammonia	Ammonia	NNP	B-NP	O
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
83	83	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
1.2	1.2	CD	I-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	O
36	36	CD	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
revealed	reveal	VBD	B-VP	O
enlarged	enlarge	VBN	I-VP	O
central	central	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
base	base	NN	B-NP	O
subsegmental	subsegmental	JJ	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
first	first	JJ	I-NP	O
degree	degree	NN	I-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
axis	axis	NN	B-NP	O
deviation	deviation	NN	I-NP	O
,	,	,	O	O
a	a	DT	O	O
left	leave	VBN	B-VP	O
?	?	.	O	O
?	?	.	O	O
anticular	anticular	JJ	B-ADJP	B-protein
?	?	.	O	I-protein
?	?	.	O	I-protein
vesicular	vesicular	JJ	B-NP	I-protein
block	block	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
ST	ST	NN	I-NP	O
or	or	CC	I-NP	O
T-wave	T-wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
15-20	15-20	CD	B-NP	O
white	white	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
trace	trace	NN	B-NP	O
bacterial	bacterial	JJ	B-ADJP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
on	on	IN	B-PP	O
9/29/03	9/29/03	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
prior	prior	JJ	I-NP	O
admission	admission	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
I	I	PRP	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
hydronephrosis	hydronephrosis	NN	I-NP	O
,	,	,	O	O
distended	distended	JJ	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
small	small	JJ	I-NP	O
stones	stone	NNS	I-NP	O
.	.	.	O	O

ETT	ETT	NNP	B-NP	O
MIBI	MIBI	NNP	I-NP	O
on	on	IN	B-PP	O
9/14/03	9/14/03	CD	B-NP	O
stress	stress	NN	I-NP	O
images	image	NNS	I-NP	O
only	only	RB	B-VP	O
performed	perform	VBN	I-VP	O
revealed	reveal	VBD	B-VP	O
small	small	JJ	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	B-protein
scar	scar	NN	I-NP	I-protein
in	in	IN	B-PP	O
mid	mid	JJ	B-NP	O
LAD/diagonal	LAD/diagonal	JJ	I-NP	O
territory	territory	NN	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
stress	stress	NN	I-NP	O
induced	induce	VBD	B-VP	O
peri-infarct	peri-infarct	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
performed	perform	VBD	B-VP	O
2/25/03	2/25/03	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
45-50	45-50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
.	.	.	O	O

Inferior	Inferior	JJ	B-NP	O
and	and	CC	I-NP	O
lateral	lateral	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
and	and	CC	O	O
positive	positive	JJ	B-NP	O
MIBI	MIBI	NN	I-NP	O
in	in	IN	B-PP	O
10/10	10/10	CD	B-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	O
blocker	blocker	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
statin	statin	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
8/25/03	8/25/03	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
.84	.84	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
which	which	WDT	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
described	describe	VBN	I-NP	O
MIBI	MIBI	NNP	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
cardiology	cardiology	NN	I-NP	O
was	be	VBD	B-VP	O
following	follow	VBG	I-VP	O
and	and	CC	O	O
recommended	recommend	VBD	B-VP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
difficulty	difficulty	NN	B-NP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
cardiology	cardiology	NN	B-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
cardiology	cardiology	NN	B-NP	O
recommended	recommend	VBD	B-VP	O
doing	do	VBG	I-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
was	be	VBD	B-VP	O
completed	complete	VBN	I-VP	O
on	on	IN	B-PP	O
3/28/03	3/28/03	CD	B-NP	O
and	and	CC	O	O
results	result	NNS	B-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

Again	Again	RB	B-ADVP	O
,	,	,	O	O
very	very	RB	B-ADJP	O
difficult	difficult	JJ	I-ADJP	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
intervention	intervention	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
habitus	habitus	NN	B-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	O
blocker	blocker	NN	I-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Cardiology	Cardiology	NN	B-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
read	read	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
BNP	BNP	NN	I-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
fluid	fluid	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	IN	B-PP	O
-LRB-	-LRB-	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
slowly	slowly	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
from	from	IN	B-PP	O
before	before	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

So	So	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
-LRB-	-LRB-	FW	I-NP	O
from	from	IN	B-PP	O
b.i.d.	b.i.d.	FW	B-NP	O
dosing	dosing	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Prior	Prior	JJ	B-NP	O
echo	echo	NN	I-NP	O
is	be	VBZ	B-VP	O
as	as	RB	I-VP	O
described	describe	VBN	I-VP	O
above	above	IN	B-PP	O
,	,	,	O	O
revealing	reveal	VBG	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
successful	successful	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
increased	increase	VBN	I-NP	O
Lasix	Lasix	NN	I-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
1/24	1/24	CD	B-NP	O
the	the	DT	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
lowered	lower	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-VP	O
b.i.d.	b.i.d.	VB	I-VP	O
dosing	dosing	NN	B-NP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
rise	rise	VB	I-VP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
normalized	normalize	VBD	B-VP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
baseline	baseline	NN	I-NP	O
on	on	IN	B-PP	O
10/14	10/14	CD	B-NP	O
At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
VT	VT	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
sotalol	sotalol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
monitored	monitor	VBN	B-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
without	without	IN	B-PP	O
alarms	alarm	NNS	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
increased	increase	VBD	B-VP	O
over	over	IN	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Secondary	Secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
BNP	BNP	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
use	use	VB	I-VP	O
BiPAP	BiPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
night	night	NN	B-NP	O
for	for	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
and	and	CC	O	O
a.m.	a.m.	RB	B-ADVP	O
NPH	NPH	NNP	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ace	ace	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
significantly	significantly	RB	I-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
NPH	NPH	NN	I-NP	B-protein
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
elevated	elevate	VBN	B-NP	O
sugars	sugar	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
more	more	RBR	B-NP	O
improved	improved	JJ	I-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
several	several	JJ	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
diabetes	diabete	NNS	B-NP	O
,	,	,	O	O
effects	effect	NNS	B-NP	O
of	of	IN	B-PP	O
paraprotein	paraprotein	NN	B-NP	B-protein
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
monoclonal	monoclonal	JJ	B-NP	B-protein
gammopathy	gammopathy	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
obesity	obesity	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Phoslo	Phoslo	NN	B-NP	O
,	,	,	I-NP	O
Calcitriol	Calcitriol	NN	I-NP	O
and	and	CC	I-NP	O
Epogen	Epogen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
hematuria	hematuria	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
urology	urology	NN	B-NP	O
.	.	.	O	O

Previously	Previously	RB	B-NP	O
extensive	extensive	JJ	I-NP	O
urological	urological	JJ	I-NP	O
workup	workup	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
including	include	VBG	B-PP	O
cystoscopy	cystoscopy	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
was	be	VBD	B-VP	O
largely	largely	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
but	but	CC	O	O
were	be	VBD	B-VP	O
poor	poor	JJ	B-NP	O
studies	study	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
large	large	JJ	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

Urology	Urology	NNP	B-NP	O
attending	attend	VBG	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
comfortable	comfortable	JJ	B-ADJP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
thought	think	VBN	B-NP	O
hematuria	hematuria	NN	I-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
significant	significant	JJ	B-NP	O
BPH	BPH	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
and	and	CC	O	O
associated	associate	VBN	B-NP	O
engorged	engorge	VBN	I-NP	O
veins	vein	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
Targis	Targis	NNP	B-NP	O
procedure	procedure	NN	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
hematuria	hematuria	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
recent	recent	JJ	B-NP	O
Foley	Foley	NNP	I-NP	O
trauma	trauma	NN	I-NP	O
from	from	IN	B-PP	O
past	past	JJ	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
urology	urology	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
urine	urine	NN	I-NP	O
cytology	cytology	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
ammonia	ammonia	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
LFTs	LFT	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
worked	work	VBN	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
which	which	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
too	too	RB	B-ADJP	O
obese	obese	JJ	I-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
per	per	IN	B-PP	O
CT.	CT.	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
myeloma	myeloma	NN	I-NP	O
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
ammonia	ammonia	NN	I-NP	O
,	,	,	O	O
versus	versus	IN	B-PP	O
a	a	DT	B-NP	O
hepatic	hepatic	JJ	I-NP	O
source	source	NN	I-NP	O
.	.	.	O	O

Ammonium	Ammonium	NN	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
83	83	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
asterixis	asterixis	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
mentation	mentation	NN	I-NP	O
while	while	IN	B-SBAR	O
inhouse	inhouse	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
medication	medication	NN	I-NP	O
of	of	IN	B-PP	O
Lactulose	Lactulose	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lab	lab	NN	I-NP	O
section	section	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
epistaxis	epistaxis	NN	B-NP	O
that	that	WDT	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
resolved	resolve	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
hematuria	hematuria	NN	B-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	IN	B-PP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
also	also	RB	B-ADVP	O
somewhat	somewhat	RB	B-VP	O
improved	improve	VBN	I-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
transfusion	transfusion	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Oncology	Oncology	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
IgA	IgA	NN	B-NP	B-protein
monoclonal	monoclonal	JJ	I-NP	O
gammopathy	gammopathy	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
Cytoxan	Cytoxan	NN	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oncologist	oncologist	NN	I-NP	O
attending	attend	VBG	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Burrows	Burrows	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
knows	know	VBZ	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
felt	feel	VBD	B-VP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
additional	additional	JJ	B-NP	O
chemo	chemo	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
Cytoxan	Cytoxan	NN	I-NP	O
therapy	therapy	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
significantly	significantly	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
complaining	complain	VBG	B-VP	O
of	of	IN	B-PP	O
muscle	muscle	NN	B-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
proximal	proximal	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
distal	distal	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
neurology	neurology	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
,	,	,	O	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
largely	largely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
deconditioning	deconditione	VBG	B-VP	O
and	and	CC	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
multiple	multiple	JJ	I-NP	O
comorbidities	comorbidity	NNS	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
myositis	myositis	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
further	further	JJ	I-NP	O
workup	workup	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	O
TO	TO	NN	I-NP	O
DO	DO	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
care	care	NN	I-NP	O
,	,	,	O	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Cardiology	Cardiology	NN	B-NP	O
,	,	,	I-NP	O
PCP	PCP	NN	I-NP	B-DNA
and	and	CC	I-NP	O
Urology	Urology	NN	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
wound	wound	NN	I-NP	O
care	care	NN	I-NP	O
dressing	dress	VBG	B-VP	O
changes	change	NNS	B-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	B-protein
325	325	CD	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
q.	q.	FW	I-NP	I-protein
6h	6h	FW	I-NP	I-protein
p.r.n.	p.r.n.	FW	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Calcitriol	Calcitriol	NN	B-NP	O
.75	.75	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Doxepin	Doxepin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subq	subq	NN	I-NP	I-protein
.	.	.	O	O

q.a.m.	q.a.m.	RB	B-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	O	O
h.s.	h.s.	NN	B-NP	B-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Atrovent	Atrovent	IN	B-PP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	NN	B-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Lactulose	Lactulose	RB	B-NP	O
30	30	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
,	,	,	O	O
instructions	instruction	NNS	B-NP	O
goal	goal	NN	I-NP	O
4-5	4-5	CD	I-NP	O
soft	soft	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Maalox	Maalox	NN	B-NP	O
50	50	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	CD	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
indigestion	indigestion	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Serax	Serax	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
insomnia	insomnia	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	B-protein
5-10	5-10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	B-NP	I-protein
q.	q.	FW	I-NP	I-protein
6h	6h	FW	I-NP	I-protein
p.r.n.	p.r.n.	FW	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Afrin	Afrin	NN	B-NP	O
2	2	CD	I-NP	O
sprays	spray	NNS	I-NP	O
nasal	nasal	JJ	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
tablets	tablet	VBZ	B-VP	O
2	2	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	VBP	B-VP	O
b.i.d.	b.i.d.	RB	B-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Zoloft	Zoloft	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Proscar	Proscar	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Simvastatin	Simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

Sotalol	Sotalol	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
21	21	CD	I-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

22	22	CD	B-NP	O
.	.	.	O	O

Ambien	Ambien	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
insomnia	insomnia	NN	I-NP	O
.	.	.	O	O

23	23	CD	B-NP	O
.	.	.	O	O

Mirapex	Mirapex	NNP	B-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
24	24	CD	I-NP	O
.	.	.	O	O

Fluticasone	Fluticasone	NN	B-NP	O
nasal	nasal	JJ	I-NP	O
spray	spray	NN	I-NP	O
1-2	1-2	CD	B-NP	O
sprays	spray	NNS	I-NP	O
nasally	nasally	RB	B-ADVP	O
q.day	q.day	VBP	B-VP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-6974828	8-6974828	CD	B-NP	O
DBSSten	DBSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
APANA	APANA	NN	B-NP	O
,	,	,	O	O
AARON	AARON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ILES	ILES	NNP	B-NP	O
,	,	,	O	O
HARLEY	HARLEY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9385120	9385120	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/28/03	3/28/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/28/03	3/28/03	CD	B-NP	O

